Source credit: U.S. Food and Drug Administration – Branch Manager for Men may be harmful due to hidden drug ingredient.
Summary: In its June 10, 2026 warning, the FDA told consumers not to purchase or use Branch Manager for Men after lab analysis found yohimbine that was not listed on the label. The agency said the product contained dangerously high levels and warned about risks including severe high blood pressure, irregular heartbeat, heart attack, seizures, stomach problems, and mental-health effects such as anxiety, confusion, tremors, mania, or psychosis in vulnerable users.
Why it matters for lifters
- Hidden-stimulant risk still matters in gym culture: Yohimbine gets discussed in cutting and energy contexts, which makes undeclared exposure especially relevant for lifters who already stack caffeine or pre-workout products.
- Stacking risk is a real concern: The FDA specifically warned that the danger rises for people using stimulants like caffeine or ephedra, ADHD medications, MAOIs, or some antidepressants.
- This is a reminder to distrust sketchy performance promises: If a supplement leans on aggressive marketing without transparent manufacturing and third-party credibility, that is exactly where hidden-ingredient problems tend to show up.
What to watch next
- Watch for retailer removals, distributor responses, and any additional FDA updates tied to this product.
- Watch your own stack for overlapping stimulant exposure instead of assuming a label tells the whole story.
- If a supplement is promising dramatic energy, libido, cutting, or body-composition changes all at once, treat that as a red flag rather than a value add.
Health disclaimer: This article is for informational purposes only and is not medical advice. If you used a product named in an FDA warning or have concerning symptoms after supplement use, seek prompt medical guidance.